Healthy Clinical Trial
Official title:
Effect of Whey Protein Supplementation Combined With Resistance Training on Body Composition, Muscular Strength, Functional Capacity, and Plasma-metabolism Biomarkers in Older Women With Sarcopenic Obesity
The main purpose of the present study was to investigate the effects of whey protein following resistance training on body composition, muscular strength, functional capacity, and plasma-metabolism biomarkers in older women with sarcopenic obesity.
This two-arm randomized, double-blind, placebo-controlled design was carried out over a
period of 16 weeks. At the beginning and end of the experiment, two weeks were allocated for
evaluations consisting of anthropometric (weeks 2 and 16), body composition (weeks 2 and 16),
one repetition maximum tests (weeks 1 and 15), functional capacity tests (weeks 1 and 15),
blood samples (weeks 2 and 16) and dietary intake measurements (weeks 1 and 15). The
anthropometric, body composition, blood samples and dietary intake measurements were carried
out in a temperature-controlled room (22-24 °C), and the RT sessions were conducted at the
university training facility.
Recruitment was carried out through newspapers, radio advertising, and home delivery of
leaflets in the central area and residential neighborhoods. All participants completed health
history and physical activity questionnaires and were included in the study if they met the
following inclusion criteria: 60 years old or more, physically independent, free from cardiac
or orthopedic dysfunction that would prevent them from performing the prescribed exercise or
exercise testing associated with the study, not receiving hormonal replacement therapy, and
completed a previous 8-week RT program. In this study, only women with SO were included. SO
was defined as a body fat mass ≥ 35%(29) combined with appendicular lean soft tissue (ALST)
less than <15.02 kg(30), assessed by dual x-ray energy absorptiometry (DXA). Participants
underwent a diagnostic graded exercise stress test with a 12-lead electrocardiogram reviewed
by a cardiologist and were released with no restrictions for participation in this
investigation.
A blinded researcher was responsible for generating random numbers for participant
allocation. Both groups were submitted to the same RT program and all participants completed
the experiment. Written informed consent was obtained from all participants after a detailed
description of investigation procedures was provided. This investigation was conducted
according to the Declaration of Helsinki and was approved by the local University Ethics
Committee The Shapiro Wilk test was used to test data distribution. Data are presented as
means, standard deviation, and z-score. The student's independent t-test and chi-square test
were used to compare groups regarding the general characteristics and clinical/medical
history (categorical variables). Two-way analysis of variance (ANOVA) for repeated measures
was used to assess between group comparisons. The effect size (ES) was calculated to verify
the magnitude of the differences by Cohen's d, where an ES of 0.20-0.49 was considered as
small, 0.50-0.79 as moderate, and ≥ 0.80 as large(41). The Z-score of the percentage changes
(from pre- to post-training) of the raw data for each parameter was calculated, as well as a
total Z-score, derived from all the components. To verify the differences between groups in
total Z-scores, an independent T test was also applied. For all statistical analyses,
significance was accepted at P < 0.05. The data were analyzed using SPSS software version
20.0 (SPSS, Inc., Chicago, IL, USA).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |